Getinge AB has today announced an offer for all of the outstanding share capital of the publicly listed UK medical technological company Huntleigh Technology PLC (Huntleigh). The offer amounts to 480 pence in cash per Huntleigh share, which corresponds to an offer premium of 28%, compared with yesterday’s closing price. The total value of the offer will be GBP409 M (SEK 5,476 M¹).
The offer has been unanimously recommended by the Board of Huntleigh who, together with the principal owner of Huntleigh, the Schild family, and certain other shareholders cumulatively representing 46.2% of the issued share capital, have irrevocably undertaken to accept the offer from Getinge AB. These irrevocable undertakings will remain binding in all circumstances, including in the case of any competing offer. In addition, we have received letters from certain institutional shareholders cumulatively representing 17.4% of the issued share capital stating their intent to accept the offer.